New shot aims to stop dangerous sugar crashes after gastric bypass

NCT ID NCT07029412

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times

Summary

This study tests an experimental drug called MBX 1416 for people who have dangerously low blood sugar after weight loss surgery. Ten adults who had gastric bypass or sleeve gastrectomy at least a year ago will receive a single injection of the drug at different doses. The goal is to see if it can raise the lowest blood sugar level during a standard meal test.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTBARIATRIC HYPOGLYCEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • MBX Biosciences Investigational Site

    RECRUITING

    Aurora, Colorado, 80045, United States

  • MBX Biosciences Investigational Site

    RECRUITING

    Morehead City, North Carolina, 28557, United States

  • MBX Biosciences Investigational Site

    RECRUITING

    Knoxville, Tennessee, 37920, United States

  • MBX Biosciences Investigational Site

    RECRUITING

    San Antonio, Texas, 78229, United States

Conditions

Explore the condition pages connected to this study.